Caricamento...
Aripiprazole added to Overweight and Obese Olanzapine-treated Schizophrenia Patients
Olanzapine treatment has been associated with clinically meaningful weight increases, hypertriglyceridemia, insulin resistance and diabetes mellitus. There are few options for olanzapine-responders who fail other antipsychotic agents. Aripiprazole is a potent (high-affinity) partial agonist at D2 an...
Salvato in:
| Pubblicato in: | J Clin Psychopharmacol |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311767/ https://ncbi.nlm.nih.gov/pubmed/19512978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0b013e31819a8dbe |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|